thorax.bmj3y
P245 Switch to budesonide/formoterol easyhaler inhalation therapy from other inhalers in COPD patients; a real-life study
Methods Adult patients (>18 years) requiring treatment with combination of ICS/LABA according to GOLD guidelines were treated with budesonide/formoterol Easyhaler 160/4.5 ug or 320/9.0 ug per ...
thorax.bmj1mon
M11 Evaluation of the quality of maintenance and reliever therapy (MART) prescribing in a large UK primary care asthma cohort
endorse combination inhalers containing an inhaled corticosteroid (ICS) and a fast and long-acting beta-2 agonist (formoterol) as the preferred reliever in asthma. ICS-formoterol used only as required ...
Hosted on MSN1mon
What Is the Optimal Reliever Therapy for Difficult-to-Control Asthma?
BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA) for asthma treatment were associated with reduced risks of severe ...
Medscape5y
The Demise of Short-Acting Beta-Agonist Therapy
Second, almost all data on as-needed ICS/LABA for asthma come from a dry-powder inhaler (DPI) formulation of budesonide/formoterol that isn't available in the United States. [5] (Only the oral ...